Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 6/20 | 0.61 |
| ▸ | HTR2A | P28223 | 2/20 | 0.55 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.51 |
| ▸ | HTR7 | P34969 | 3/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | STAT6 | P42226 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31618142 | 0.90 | CYP2C9 (0.54) | HTR6HTR2AAOC3HTR1AALDH1A1 | |
| Fumaric Acid SCHEMBL31713032 | 0.87 | HTR7 (0.53) | HTR6HTR2AHTR7HTR1AALDH1A1 | |
| SCHEMBL2937482 | 0.82 | AOC3 (0.73) | HTR6HTR2AAOC3HTR7HTR1A | |
| SCHEMBL11673960 | 0.82 | ALOX5 (0.54) | HTR1ACYP2C9TAAR1 | |
| Hydrochloric Acid SCHEMBL8509376 | 0.80 | AOC3 (0.71) | HTR6HTR2AAOC3HTR7ALDH1A1 | |
| SCHEMBL11268828 | 0.79 | HTR2A (0.67) | HTR6HTR2AHTR7HTR1A | |
| SCHEMBL9122622 | 0.79 | TAAR1 (0.67) | HTR2AHTR1ATAAR1 | |
| SCHEMBL8941793 | 0.79 | SLC2A1 (0.47) | HTR2AHTR1ACYP2C9TAAR1 | |
| SCHEMBL31331974 | 0.79 | SLC2A1 (0.47) | HTR2AHTR1ACYP2C9TAAR1 | |
| SCHEMBL31332014 | 0.79 | TAAR1 (0.67) | HTR2AHTR1ATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250333371-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2025-10-30 | — | — | US | disclosed |
| EP-4532462-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2025-04-09 | — | — | EP | disclosed |
| CN-119384406-A | Compounds of formula (I) | 赛洛私人有限公司 | 2025-01-28 | — | — | CN | disclosed |
| WO-2023230649-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2023-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250333371-A1 | COMPOUNDS | SDHA, PYGB, SLC18A2 | HTR6 187/4885HTR2A 225/4885AOC3 703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.